DNL-919 (TAK-920) is a human IgG1 monoclonal antibody (mAb) that targets TREM-2. It is utilized in Alzheimers disease research. The recommended isotype control is Human IgG1 kappa, Isotype Control.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted